Results 31 to 40 of about 38,655 (210)

Annular bullous pemphigoid: A case report and review of literature

SAGE Open Medical Case Reports, 2022
Bullous pemphigoid is an autoimmune blistering disease that primarily affects the geriatric population. It often presents as urticarial erythematous plaques, which evolve into subepidermal blisters accompanied by pruritus.
Steffie Arès, Darosa Lim, Sungmi Jung, Danielle Bouffard, Alexandra Mereniuk   +4 more
doaj   +1 more source

Pemphigoid diseases in infancy and childhood. A review of the literature

Przegląd Dermatologiczny, 2023
Bullous pemphigoid is an autoimmune blistering disease that very rarely affects children. Clinical differences in locations of skin lesions led to the distinction of infantile versus childhood pemphigoid. Mucous membranes can be affected.
Magdalena Jałowska, Julia Jałowska, Marian Dmochowski   +2 more
doaj   +1 more source

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid

Frontiers in Immunology, 2021
Bullous pemphigoid (BP) is a blistering autoimmune skin disease. Omalizumab, a monoclonal antibody directed to IgE, showed a beneficial effect in treatment of recalcitrant BP in case series.
S. M. Seyed Jafari, L. Feldmeyer, S. Bossart, D. Simon, C. Schlapbach, L. Borradori   +5 more
semanticscholar   +1 more source

Association between COVID-19 vaccination and bullous pemphigoid – a case series and literature review

SAGE Open Medical Case Reports, 2022
Bullous pemphigoid is an acquired autoimmune blistering dermatosis that is commonly associated with high morbidity and mortality. New-onset bullous pemphigoid following vaccinations has rarely been reported in the literature.
Vincent Wan, Dilys Chen, Carolyn J Shiau, Gordon W Jung   +3 more
doaj   +1 more source

Clinical periodontal diagnosis

Periodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi, Andrea Roccuzzo, Jean‐Claude Imber, Alexandra Stähli, Björn Klinge, Niklaus P. Lang   +5 more
wiley   +1 more source

Paraneoplastic bullous pemphigoid – A sign of clear cell renal carcinoma

Urology Case Reports, 2020
Paraneoplastic bullous pemphigoid is a rare paraneoplastic syndrome. Rash is pruritic, with erythematous eruption of large subepidermal bullae over skin and often mucosal surfaces.
Stuart R. Jackson, Jakob Koestenbauer, Adam P. Carroll, Than-Htike Oo, Shaun Chou, Balasubramaniam Indrajit   +5 more
doaj   +1 more source

A Rare Type of Bullous Disorder in a Child. Can It Be Chronic Bullous Disease of Childhood? [PDF]

Clin Case Rep
ABSTRACT Chronic bullous disease of childhood (CBDC), also known as childhood linear IgA bullous dermatosis, is a rare autoimmune disorder characterized by sub‐epidermal blistering and linear deposition of immunoglobulin A at the demo‐epidermal junction.
Yadav R, Poudel I, Poudyal Y, Chaudhary N.   +3 more
europepmc   +2 more sources

Bullous Pemphigoid Bullous Pemphigoid

, 2018
Bullous pemphigoid (BP) is a chronic, acquired, autoimmune bullous disease character- ized by subepidermal bullae. It is usually seen in the elderly but, rarely, may also be seen in children.
Derya Yayla, Pelin Hızlı, Yeşim Yayla
semanticscholar   +1 more source

Incidence of pemphigoid diseases in Northern Germany in 2016 – first data from the Schleswig‐Holstein Registry of Autoimmune Bullous Diseases

Journal of the European Academy of Dermatology and Venereology, 2021
Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for cell‐matrix ...
N. Beek, A. Weidinger, S. W. Schneider, A. Kleinheinz, R. Gläser, M. Holtsche, A. Georg, C. Hammers, F. Hübner, Ana L Lima, D. Gola, C. Sadik, D. Zillikens, A. Katalinic, E. Schmidt, I. König   +15 more
semanticscholar   +1 more source

Dupilumab for the treatment of nivolumab-induced bullous pemphigoid: a case report and review of the literature.

Dermatology Online Journal, 2021
Immune checkpoint inhibitors, a relatively new class of drugs, are used to treat a variety of malignancies. These drugs have a known association with cutaneous side effects, such as bullous pemphigoid. Bullous pemphigoid is a pruritic blistering disorder
E. Klepper, H. N. Robinson
semanticscholar   +1 more source